carcinogenicity testing
FDA Representative Gives Insights into Success and Accuracy in Genotoxicity and Carcinogenicity Testing in Exclusive Podcast Interview
September 09 by Pharma IQ NewsPharma IQ has interviewed Dr. Timothy Robison, Pharmacology and Toxicity Reviewer at the US Food & Drug Administration (FDA) and CDER, in an exclusive podcast ahead of his presentations at the Gen...
How to Identify and Control Genotoxic Impurities
August 08 by Pharma IQDr. Andrew Teasdale, Senior QA Executive at AstraZeneca, joins Helen Winsor from Pharma IQ, to discuss genotoxicity and carcinogenicity testing. He begins by summing up the challenges that exist with...
Pre-Clinical Toxicity: Avoiding Common Mistakes in Early Development
June 21 by Pharma IQDr. Mitchell Friedman, Director of Toxicology at Takeda Pharmaceuticals, discusses pre-clinical toxicity and avoiding common mistakes in early development so as to secure patient safety and better ROI...
